What is the appropriate evaluation and management for an adult male with ferritin around 519 ng/mL and serum iron around 206 µg/dL suggesting iron overload?

Evaluation and Management of Elevated Ferritin and Serum Iron in an Adult Male

Your patient requires immediate measurement of fasting transferrin saturation to determine whether this represents true iron overload (hereditary hemochromatosis) or secondary hyperferritinemia from inflammation, liver disease, or metabolic causes. 1, 2

Critical First Step: Transferrin Saturation

The single most important test is transferrin saturation (TS), calculated as serum iron ÷ total iron-binding capacity × 100. 1, 2 This test distinguishes true iron overload from the 90% of hyperferritinemia cases caused by non-iron-overload conditions. 2

If TS ≥ 45%: Primary Iron Overload Pathway

• Immediately order HFE genetic testing for C282Y and H63D mutations. 1, 2 A TS ≥ 45% indicates possible hereditary hemochromatosis or other primary iron-overload disorders. 1

• C282Y homozygosity confirms HFE-related hereditary hemochromatosis and accounts for 80–90% of clinically manifest cases. 1 This genotype warrants therapeutic phlebotomy. 1, 3

• C282Y/H63D compound heterozygosity produces milder iron overload and usually requires additional risk factors (alcohol, fatty liver) to become clinically evident. 1

• With ferritin 519 ng/mL, liver biopsy is NOT required to initiate phlebotomy, as the threshold for mandatory biopsy is ferritin >1000 µg/L with abnormal liver enzymes or age >40 years. 1, 2 The ferritin <1000 µg/L has a 94% negative predictive value for advanced fibrosis. 1, 2

If TS < 45%: Secondary Hyperferritinemia Pathway

• Iron overload is excluded with >90% certainty when TS <45%. 2 Do NOT proceed with HFE genetic testing. 2

• Investigate secondary causes, which account for >90% of elevated ferritin cases: 2

  • Chronic alcohol consumption (increases iron absorption and causes hepatocellular injury) 2
  • Non-alcoholic fatty liver disease/metabolic syndrome (ferritin reflects hepatocellular injury and insulin resistance, not iron overload) 2
  • Inflammation (ferritin is an acute-phase reactant) 1, 2
  • Liver disease (viral hepatitis, alcoholic hepatitis, acute hepatitis) 2
  • Malignancy (solid tumors, lymphomas, hepatocellular carcinoma) 2
  • Cell necrosis (muscle injury, hepatocellular necrosis) 2

Essential Concurrent Laboratory Tests

Order these tests simultaneously with transferrin saturation: 1, 2

• Complete blood count to evaluate for polycythemia, anemia, or thrombocytopenia 1
• Liver enzymes (AST, ALT) to detect hepatocellular injury 1, 2
• Inflammatory markers (CRP, ESR) to exclude inflammation that falsely raises ferritin 1, 2
• Fasting glucose and HbA1c for diabetes screening 1
• Creatine kinase to evaluate for muscle necrosis 2

Risk Stratification by Ferritin Level

Your patient's ferritin of 519 ng/mL falls into the low-risk category (<1000 µg/L): 1, 2

• Ferritin <1000 µg/L: Low risk of organ damage; 94% negative predictive value for advanced hepatic fibrosis 1, 2
• Ferritin 1000–10,000 µg/L: Higher risk of advanced fibrosis/cirrhosis if iron overload is present; the combination of ferritin >1000 µg/L, elevated aminotransferases, and platelet count <200,000/µL predicts cirrhosis in 80% of C282Y homozygotes 1, 2
• Ferritin >10,000 µg/L: Rarely represents simple iron overload; requires urgent specialist referral for life-threatening conditions (hemophagocytic lymphohistiocytosis, adult-onset Still's disease) 2

Additional Imaging if TS ≥ 45%

• Liver MRI with T2 or R2** provides non-invasive quantification of hepatic iron concentration 1, 4
• Abdominal ultrasound to evaluate for fatty liver, chronic liver disease, or hepatomegaly 2

Critical Pitfalls to Avoid

• Never diagnose iron overload based on ferritin alone without confirming TS ≥ 45%. 1, 2 Ferritin rises as an acute-phase reactant in inflammation, liver disease, malignancy, and tissue necrosis independent of iron stores. 1, 2

• Do not order HFE genetic testing when TS <45%, as this leads to misdiagnosis and unnecessary phlebotomy. 2

• Do not assume iron overload when TS <45%; in the general population, iron overload is NOT the most common cause of elevated ferritin. 2

• Do not delay phlebotomy awaiting liver biopsy when ferritin <1000 µg/L and liver enzymes are normal; biopsy is unnecessary for initiating treatment. 1

• Do not attribute hyperferritinemia solely to inflammation without evaluating transferrin saturation, as hemochromatosis can coexist with inflammatory states. 1

Management Based on Final Diagnosis

If Hereditary Hemochromatosis Confirmed (C282Y homozygote with TS ≥45%)

Initiate therapeutic phlebotomy immediately: 1, 3

• Induction phase: Remove 500 mL blood weekly until ferritin reaches 50–100 µg/L; each session removes ~200–250 mg iron 1
• Maintenance phase: Phlebotomy every 2–4 months to keep ferritin 50–100 µg/L and TS <50% 1
• Screen all first-degree relatives with HFE genotyping and iron studies 1

Lifestyle modifications: 1

• Avoid or strictly limit alcohol
• Avoid raw or undercooked shellfish (>50% mortality from Vibrio vulnificus in iron-overloaded patients)
• Do not use iron supplements or high-dose vitamin C (>500 mg/day)

If Secondary Hyperferritinemia (TS <45%)

Treat the underlying condition, not the elevated ferritin: 2

• NAFLD/metabolic syndrome: Weight loss, metabolic syndrome management 2
• Alcohol-related: Alcohol cessation 2
• Inflammatory conditions: Disease-specific anti-inflammatory therapy 2
• Malignancy: Oncologic treatment 2

Phlebotomy is NOT indicated unless TS ≥45% with evidence of end-organ damage. 2

When to Refer to Hepatology or Hematology

Refer immediately if: 2

• Ferritin >1000 µg/L with elevated bilirubin
• Ferritin >10,000 µg/L regardless of other findings
• Confirmed TS ≥45% on repeat testing
• Clinical evidence of cirrhosis (platelet count <200,000/µL, elevated bilirubin, hepatomegaly)
• Confirmed C282Y homozygosity requiring therapeutic phlebotomy